SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : TAVA Technologies (TAVA-NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: C.K. Houston who wrote (14968)4/17/1998 5:13:00 PM
From: C.K. Houston  Read Replies (4) of 31646
 
In spite of all this whining about PR, this chart looks d*mn good to me! Volatility before warrant conversion was expected.
iqc.com

Once we have full NMS listing, I imagine PR releases will be handled differently. I view this conservative approach to PR releases as smart, at this point in time. I want NMS listing. Anything that could be construed as "hype" by the company, to manipulate stock price could kill this. Management understands this.

Fortunately Jenkins has a law background, in addition to engineering. Both requiring logic and analysis. He and his management team have a better grasp of what's going on "behind the scenes" than any poster on this thread.

While everyone's been nit-picking about PR and watching ticks today, I've been revising my 53 page Medical Report for Healthcare Professionals to include today's news.

Why? Because I got an email this morning from the UK Y2K manager from a MAJOR pharmaceutical company (listed below), requesting my report.

TAVA Pharmaceutical Clients Core Business:
- Abbott Laboratories
- Baxter
- DuPont-Merck
- Eli-Lilly
- Genentech Inc
- Glaxo-Wellcome
- Hoffman-LaRoche
- Merck & Co
- Pfizer
- Wyeth Ayerst

TAVA Pharmaceutical Clients Year 2000 Assessment & Remediation:
- Bristol-Meyers Squibb - 125 sites worldwide

I won't identify who it is. It's not Bristol-Meyers Squibb. So don't bother trying to guess.

Here's the email:

"My name is XXXX XXXXX and I am a Year 2000 project manager within the UK part of XXXXXX. There is not much information around on medical devices, and embedded systems will form a large part of my project. Could you please mail me a copy of your Medical Report?"

The embedded system problem within medical devices is a SERIOUS issue. The lack of available information out there is appalling.

This will be a REAL money-maker for TAVA and CMED. Will take a few months to see impact on revenues. But when you do ... watch out!!

You may have noticed, that many of the people who contributed in-depth ... don't anymore. It's because of all of this trading chat and small talk on THIS thread. I will soon be one of them - unless some of this small talk goes to the "TAVA Trading" thread. Fine with me, because what I do takes a LOT of time.
Subject 16061

Cheryl

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext